These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7866820)

  • 1. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.
    Labenz J; Stolte M; Rühl GH; Becker T; Tillenburg B; Sollböhmer M; Börsch G
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):9-11. PubMed ID: 7866820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
    Moayyedi P; Sahay P; Tompkins DS; Axon AT
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):835-40. PubMed ID: 8574714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
    Chu KM; Kwok KF; Law SY; Wong J
    Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
    Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
    Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
    Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori.
    Chu KM; Choi HK; Tuen HH; Law SY; Branicki FJ; Wong J
    Am J Gastroenterol; 1998 Sep; 93(9):1436-42. PubMed ID: 9732921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
    Zullo A; Rinaldi V; Pugliano F; Diana F; Attili AF
    Am J Gastroenterol; 1997 Nov; 92(11):2029-31. PubMed ID: 9362185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.
    Jaup BH; Norrby A
    Am J Gastroenterol; 1995 Jun; 90(6):943-5. PubMed ID: 7771426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
    Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V
    Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
    Chan KL; Zhou H; Ng DK; Tam PK
    J Pediatr Surg; 2001 Jul; 36(7):1008-11. PubMed ID: 11431766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection.
    Tursi A; Cammarota G; Papa A; Montalto M; Veneto G; Capelli G; Cuoco L; Branca G; Fedeli G; Gasbarrini G
    Hepatogastroenterology; 1996; 43(10):859-62. PubMed ID: 8884304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.